Indoco Remedies Q1 Results Live : Indoco Remedies declared their Q1 results on 23 Jul, 2024. The topline increased by 1.17% & the profit decreased by 89.22% YoY. As compared to the previous quarter the revenue declined by 4.04% and the profit decreased by 88.41%.
The Selling, general & administrative expenses rose by 10.15% q-o-q & increased by 6.25% Y-o-Y.
The operating income was down by 52.21% q-o-q & decreased by 50.96% Y-o-Y.
The EPS is ₹0.2 for Q1 which decreased by 92.37% Y-o-Y.
Indoco Remedies has delivered -3.56% return in the last 1 week, -13.37% return in last 6 months and -19.17% YTD return.
Currently the Indoco Remedies has a market cap of ₹2944.76 Cr and 52wk high/low of ₹415 & ₹286.6 respectively.
As of 24 Jul, 2024 out of 3 analysts covering the company, 1 analyst has given Hold rating, 1 analyst has given Buy rating &1 analyst has given Strong Buy rating.
The consensus recommendation as on 24 Jul, 2024 was to Buy.
Indoco Remedies Financials
Period | Q1 | Q4 | Q-o-Q Growth | Q1 | Y-o-Y Growth |
---|---|---|---|---|---|
Total Revenue | 431.49 | 449.64 | -4.04% | 426.5 | +1.17% |
Selling/ General/ Admin Expenses Total | 97.26 | 88.3 | +10.15% | 91.54 | +6.25% |
Depreciation/ Amortization | 27.52 | 26.23 | +4.92% | 19.88 | +38.43% |
Total Operating Expense | 411.24 | 407.27 | +0.97% | 385.21 | +6.76% |
Operating Income | 20.25 | 42.37 | -52.21% | 41.29 | -50.96% |
Net Income Before Taxes | 6.97 | 32.98 | -78.87% | 33.91 | -79.45% |
Net Income | 2.63 | 22.7 | -88.41% | 24.39 | -89.22% |
Diluted Normalized EPS | 0.2 | 1 | -80.05% | 2.62 | -92.37% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
MoreLess